Other News To Note
Thursday, January 19, 2012
Huya Bioscience International LLC, of San Diego, entered an agreement with Tianjin Institute of Pharmaceutical Research (TIPR) in Tianjin, China, to promote new drug development in China and worldwide. Under the terms, Huya will have the first opportunity to evaluate certain R&D projects conducted at TIPR and agreed to provide support and assistance as needed.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.